Member Exclusive News

The week in industry: First-in-class psoriasis treatment approved in China

This week: Lonza and Chr Hansen aim to position themselves as leaders in the live biotherapeutic product industry, the US FDA approves an IND application for the first allogeneic CAR-T to treat multiple myeloma patients and report shows 17 innovative sickle cell medicines are in development.

Go to the profile of RxNet
Apr 04, 2019
0
0

Please sign in or register for FREE

No comments yet.